BridgeMD
Prevention study for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
Official title Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer
ClinicalTrials.gov ID: NCT07092111
What this study is testing
- What it's testing
- Evaluate the Efficacy of Auricular Acupuncture Therapy via the Seirin Pyonex Needles in the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75, women only
You may be able to join if
- Patients with breast cancer diagnosed with stage I-III;
- Planned to receive 4 cycles of taxane chemotherapy and have not taken neurostable drugs within three months;
- 18 years old≤ age≤ 75 years old, female;
- people voluntarily participate in this trial and sign the informed consent form.
You likely can't join if
- Patients who have had acupuncture treatment in the past;
- After examination by a doctor, there is a local infection at or near the acupuncture site, which is not suitable for acupuncture.
- Platelets\< 50,000/μL;
- Patients with CIPN≥1 grade 1 (NCI-CTCAE);
- Peripheral neuropathy or other neuropathic pain caused by diabetes mellitus or other factors related to HIV infection.
The study team makes the final eligibility decision.
Where it's taking place
- Nanjing, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanjing, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.